ADMA Biologics, Inc.

ADMA Biologics, Inc. - ROEverified

ADMA

Price:

$8.31

Market Cap:

$1.93B

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio includes BIVIGAM and ASCENIV, both intravenous immune globulin (IVIG) treatments prescribed for primary humoral immunodeficiency (PI). Additionally, the company offers Nabi-HB, utilized for immediate treatment following acute exposure to the Hepatitis B virus and other specified exposures. Beyond its existing...[Read more]

Industry

Biotechnology

IPO Date

2013-10-17

Stock Exchange

NASDAQ

Ticker

ADMA

The ROE as of June 2026 (TTM) for ADMA Biologics, Inc. (ADMA) is 38.97%

According to ADMA Biologics, Inc.’s latest financial reports and current stock price. The company's current ROE is 38.97%. This represents a change of 299.74% compared to the average of 9.75% of the last 4 quarters.

ADMA Biologics, Inc. (ADMA) Historical ROE (quarterly & annually)

How has ADMA ROE performed in the past?

The mean historical ROE of ADMA Biologics, Inc. over the last ten years is -30.09%. The current 38.97% ROE has changed -229.50% with respect to the historical average. Over the past ten years (40 quarters), ADMA's ROE was at its highest in in the September 2016 quarter at 2.85%. The ROE was at its lowest in in the June 2016 quarter at -153.53%.

Quarterly (TTM)
Annual

Average

-30.09%

Median

-47.06%

Minimum

-332.53%

Maximum

437.83%

ADMA Biologics, Inc. (ADMA) ROE by Quarter and Year

Discovering the peaks and valleys of ADMA Biologics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 206.50%

Maximum Annual ROE = 437.83%

Minimum Annual Increase = -371.17%

Minimum Annual ROE = -332.53%

Quarterly (TTM)
Annual
YearROEChange
202530.78%-45.65%
202456.64%-371.17%
2023-20.89%-51.84%
2022-43.37%-14.55%
2021-50.75%-40.87%
2020-85.83%-53.43%
2019-184.32%-44.57%
2018-332.53%206.50%
2017-108.49%-124.78%
2016437.83%-120.00%

ADMA Biologics, Inc. (ADMA) Average ROE

How has ADMA ROE performed in the past?

The current ROE of ADMA Biologics, Inc. (ADMA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

22.18%

5-year avg

-5.52%

10-year avg

-30.09%

ADMA Biologics, Inc. (ADMA) ROE vs. Peers

How is ADMA’s ROE compared to its peers?

ADMA Biologics, Inc.’s ROE is less than ACADIA Pharmaceuticals Inc. (35.65%), greater than Praxis Precision Medicines, Inc. (-43.02%), greater than Belite Bio, Inc (-26.70%), less than Ligand Pharmaceuticals Incorporated (16.19%), less than Soleno Therapeutics, Inc. (22.86%), greater than Mirum Pharmaceuticals, Inc. (-289.33%), greater than Dyne Therapeutics, Inc. (-58.28%), greater than Crinetics Pharmaceuticals, Inc. (-43.96%), greater than Telix Pharmaceuticals Limited (-1.72%), less than Ultragenyx Pharmaceutical Inc. (1.57%),

Build a custom stock screener for ADMA Biologics, Inc. (ADMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADMA Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ADMA Biologics, Inc. (ADMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ADMA Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is ADMA Biologics, Inc.'s ROE?

How is the ROE calculated for ADMA Biologics, Inc. (ADMA)?

What is the highest ROE for ADMA Biologics, Inc. (ADMA)?

What is the 3-year average ROE for ADMA Biologics, Inc. (ADMA)?

What is the 5-year average ROE for ADMA Biologics, Inc. (ADMA)?

How does the current ROE for ADMA Biologics, Inc. (ADMA) compare to its historical average?